Harbor Investment Advisory’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.3K Buy
+1,566
New +$38.9K ﹤0.01% 747
2023
Q2
Sell
-659
Closed -$26.4K 1374
2023
Q1
$26.4K Sell
659
-214
-25% -$9.18K ﹤0.01% 857
2022
Q4
$40.4K Hold
873
0.01% 744
2022
Q3
$36K Hold
873
0.01% 776
2022
Q2
$52K Buy
873
+118
+16% +$7.26K 0.01% 696
2022
Q1
$55K Hold
755
0.01% 726
2021
Q4
$63K Hold
755
0.01% 673
2021
Q3
$68K Hold
755
0.01% 639
2021
Q2
$72K Sell
755
-75
-9% -$7.81K 0.01% 595
2021
Q1
$95K Sell
830
-73
-8% -$9.94K 0.01% 494
2020
Q4
$125K Buy
903
+153
+20% +$18.1K 0.02% 404
2020
Q3
$62K Buy
750
+308
+70% +$25.5K 0.01% 451
2020
Q2
$35K Hold
442
0.01% 512
2020
Q1
$20K Buy
+442
New +$22.9K 0.01% 580

Other funds holding RARE